BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21931046)

  • 1. Localization of sclerotic-type chronic graft-vs-host disease to sites of skin injury: potential insight into the mechanism of isomorphic and isotopic responses.
    Martires KJ; Baird K; Citrin DE; Hakim FT; Pavletic SZ; Cowen EW
    Arch Dermatol; 2011 Sep; 147(9):1081-6. PubMed ID: 21931046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isomorphic sclerotic-type cutaneous chronic graft-versus-host disease: report and review of chronic graft-versus-host disease in a cutaneous immunocompromised district.
    Cohen PR
    Dermatol Ther (Heidelb); 2013 Dec; 3(2):215-22. PubMed ID: 24318412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease.
    Clark J; Yao L; Pavletic SZ; Krumlauf M; Mitchell S; Turner ML; Cowen EW
    Arch Dermatol; 2009 Aug; 145(8):918-22. PubMed ID: 19687424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Anatomic Distribution of Skin Involvement in Patients with Incident Chronic Graft-versus-Host Disease.
    Gandelman JS; Zic J; Dewan AK; Lee SJ; Flowers M; Cutler C; Pidala J; Chen H; Jagasia MH; Tkaczyk ER
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):279-286. PubMed ID: 30219700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lichen Sclerosus on the Sites of Striae Distensae and a Surgical Scar in a Patient with Coexistent Morphea.
    Baykal C; Kobaner GB; Copur S; Buyukbabani N
    Acta Dermatovenerol Croat; 2019 Mar; 27(1):44-46. PubMed ID: 31032793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidity.
    Jachiet M; de Masson A; Peffault de Latour R; Rybojad M; Robin M; Bourhis JH; Xhaard A; Dhedin N; Sicre de Fontbrune F; Suarez F; Barete S; Parquet N; Nguyen S; Ades L; Rubio MT; Wittnebel S; Bagot M; Socié G; Bouaziz JD
    Br J Dermatol; 2014 Jul; 171(1):63-8. PubMed ID: 24404963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrater reproducibility of the Myoton and durometer devices to quantify sclerotic chronic graft-versus-host disease.
    Ghosh S; Baker L; Chen F; Khera Z; Vain A; Zhang K; Hood A; Smith H; Chen H; Jagasia M; Tkaczyk E
    Arch Dermatol Res; 2023 Nov; 315(9):2545-2554. PubMed ID: 37227518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrater Reliability of Clinical Grading Measures for Cutaneous Chronic Graft-vs-Host Disease.
    Cardones AR; Sullivan KM; Green C; Chao NJ; Rowe-Nichols K; Bañez LL; Burton CS; Horwitz ME; Long GD; Rao CL; Sarantopoulos S; Sidhu-Malik N; Sung AD; Hall RP
    JAMA Dermatol; 2019 Jul; 155(7):833-837. PubMed ID: 30994873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narrowband UV-B Phototherapy for Steroid-Refractory Sclerotic Chronic Cutaneous Graft-vs-Host Disease.
    Sorenson E; McAndrew R; Patel V; Logan AC; Koo J; Levin E
    JAMA Dermatol; 2015 Jun; 151(6):635-7. PubMed ID: 25806783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic characteristics of cutaneous chronic graft-versus-host diseases: a retrospective study in Korean patients.
    Kim SJ; Choi JM; Kim JE; Cho BK; Kim DW; Park HJ
    Int J Dermatol; 2010 Dec; 49(12):1386-92. PubMed ID: 21155089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host disease.
    Alsuliman T; Magro L; Coiteux V; Gauthier J; Srour M; Lionet A; Beauvais D; Yakoub-Agha I
    Curr Res Transl Med; 2020 Apr; 68(2):71-76. PubMed ID: 31631014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myofibroblasts generated in culture from sclerotic skin lesions of a patient with extensive chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation are of recipient origin.
    Goussetis E; Spiropoulos A; Theodosaki M; Stefanaki K; Petrakou E; Graphakos S
    Stem Cells Dev; 2010 Sep; 19(9):1285-7. PubMed ID: 20001597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nedocromil sodium ameliorates skin manifestations in a murine model of chronic graft-versus-host disease.
    Levi-Schaffer F; Goldenhersh MA; Segal V; Nagler A
    Bone Marrow Transplant; 1997 Apr; 19(8):823-8. PubMed ID: 9134176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exuberant granulation tissue associated with chronic graft-versus-host disease after transplantation of peripheral blood progenitor cells.
    Barnadas MA; Brunet S; Sureda A; López R; Curell R; Sierra J; Alomar A
    J Am Acad Dermatol; 1999 Nov; 41(5 Pt 2):876-9. PubMed ID: 10534676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic risk factors for sclerotic graft-versus-host disease.
    Inamoto Y; Martin PJ; Flowers ME; Lee SJ; Carpenter PA; Warren EH; Geraghty DE; Lee N; Boeckh MJ; Storer BE; Levine DM; Fan W; Zhao LP; Hansen JA
    Blood; 2016 Sep; 128(11):1516-24. PubMed ID: 27313329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral disease profiles in chronic graft versus host disease.
    Bassim CW; Fassil H; Mays JW; Edwards D; Baird K; Steinberg SM; Cowen EW; Naik H; Datiles M; Stratton P; Gress RE; Pavletic SZ
    J Dent Res; 2015 Apr; 94(4):547-54. PubMed ID: 25740857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review.
    Kroft EB; Berkhof NJ; van de Kerkhof PC; Gerritsen RM; de Jong EM
    J Am Acad Dermatol; 2008 Dec; 59(6):1017-30. PubMed ID: 18835066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous Chronic Graft Versus Host Disease Following Allogeneic Haematopoietic Stem Cell Transplantation in Children: A Retrospective Study.
    Shreberk-Hassidim R; Neumark M; Greenberger S; Goldstein G; Hassidim A; Dukler Y; Maly A; Stepensky P; Molho-Pessach V
    Acta Derm Venereol; 2018 Feb; 98(2):206-211. PubMed ID: 29057425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Toll-like receptor 4 signaling in cutaneous chronic graft-versus-host disease.
    Weng J; Lai P; Geng S; Luo C; Wu S; Ling W; Deng C; Huang X; Lu Z; Du X
    Clin Transplant; 2015 Jun; 29(6):547-54. PubMed ID: 25845646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial reconstitution of cutaneous microvessels in long-term survivors after allogeneic bone marrow transplantation.
    Haeusermann P; Kump E; Rovó A; Tichelli A; Itin P; Gratwohl A; Biedermann BC
    Dermatology; 2009; 219(1):32-41. PubMed ID: 19407437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.